DLD Asset Management’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
Other funds holding LPCN
JGC
DLD Asset Management's LPCN Position: Q1 2018 in Review
DLD Asset Management sold out of Lipocine (LPCN) in Q1 2018, closing a stake of 7,000 shares — an estimated $195K sold.
DLD Asset Management first reported a position in LPCN in Q2 2017 and held it in 3 quarters. The position peaked at $1.59M in Q3 2017. 27 funds tracked by Wall St. Rank hold LPCN as of Q1 2018.
- DLD Asset Management reported no remaining Lipocine position as of Q1 2018 after selling out during the quarter.
- DLD Asset Management sold 7,000 Lipocine shares in Q1 2018, an estimated $195K.
- DLD Asset Management first reported a position in Lipocine in Q2 2017 and held it in 3 quarters.
- DLD Asset Management's Lipocine position peaked at $1.59M in Q3 2017.
- 27 funds tracked by Wall St. Rank held Lipocine as of Q1 2018.
Based on DLD Asset Management's 13F filing for Q1 2018, filed 14 May 2018.